000 | 03636cam a2200625 i 4500 | ||
---|---|---|---|
001 | on1374215010 | ||
003 | OCoLC | ||
005 | 20241121073136.0 | ||
006 | m d | ||
007 | cr cnu---unuuu | ||
008 | 230329t20232023enk ob 001 0 eng d | ||
040 |
_aN$T _beng _erda _epn _cN$T _dN$T _dUKMGB _dOCLCF _dOCLCO |
||
015 |
_aGBC2I2046 _2bnb |
||
016 | 7 |
_a020774092 _2Uk |
|
019 | _a1376273950 | ||
020 |
_a9781839165887 _q(electronic bk.) |
||
020 |
_a183916588X _q(electronic bk.) |
||
020 | _z1788018982 | ||
020 | _z9781788018982 | ||
035 |
_a3580101 _b(N$T) |
||
035 |
_a(OCoLC)1374215010 _z(OCoLC)1376273950 |
||
037 |
_a3-178-9781839165887 _bIngram Content Group |
||
050 | 4 |
_aRS403 _b.H34 2023 |
|
082 | 0 | 4 |
_a615.19 _223 |
049 | _aMAIN | ||
245 | 0 | 4 |
_aThe handbook of medicinal chemistry : _bprinciples and practice / _cedited by Simon E. Ward and Andrew M. Davis. |
250 | _a2nd edition. | ||
264 | 1 |
_aCambridge : _bRoyal Society of Chemistry, _c[2023] |
|
264 | 4 | _c�2023 | |
300 | _a1 online resource. | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
588 | 0 | _aPrint version record. | |
500 | _aPrevious edition: 2015. | ||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aPhysicochemical Properties; Synthesis in Medicinal Chemistry; Useful Computational Chemistry Tools for Medicinal Chemistry; Structure-based Design for Medicinal Chemists; Fragment-based Ligand Discovery; Machine Learning in Drug Design; Drug Metabolism; ADME Optimization in Drug Discovery; Molecular Biology for Medicinal Chemists; Assays; In Vitro Biology: Measuring Pharmacological Activity That Will Translate to Clinical Efficacy; Animal Models: Practical Use and Considerations; Bioinformatics for Medicinal Chemistry; Translational Science; Discovery Toxicology in Lead Optimization; Toxicology and Drug Development; Patents for Medicines; Target Validation for Medicinal Chemists; Lead Optimisation: What you should know!; Pharmaceutical Properties -- The Importance of Solid Form Selection; The Medicinal Chemistry and Process Chemistry Interface; Clinical Drug Development; SMN2 Splicing Modification by Small Molecules -- A Blueprint to Tackle the Underlying Genetic Cause of Many Underserved Diseases; The Discovery of Checkpoint Kinase 1 Inhibitors: From Fragments to Clinical Candidate; Medicinal Chemistry for Neglected Diseases -- Malaria, Tuberculosis, Sleeping Sickness, Leishmaniasis and River Blindness; New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery | |
590 | _aWorldCat record variable field(s) change: 650 | ||
650 | 0 |
_aPharmaceutical chemistry. _917664 |
|
650 | 0 |
_aDrug development. _915871 |
|
650 | 0 |
_aDrugs. _923599 |
|
650 | 2 |
_aChemistry, Pharmaceutical _923600 |
|
650 | 2 |
_aPharmaceutical Preparations _923601 |
|
650 | 6 |
_aChimie pharmaceutique. _923602 |
|
650 | 6 |
_aM�edicaments _xD�eveloppement. _915872 |
|
650 | 6 |
_aM�edicaments. _923603 |
|
650 | 7 |
_aDrug development _2fast _915871 |
|
650 | 7 |
_aPharmaceutical chemistry _2fast _917664 |
|
700 | 1 |
_aWard, Simon E. _q(Simon Edward), _eeditor. _923604 |
|
700 | 1 |
_aDavis, Andrew M. _c(Chemist), _eeditor. _923605 |
|
776 | 0 | 8 |
_iPrint version: _tHANDBOOK OF MEDICINAL CHEMISTRY. _d[Place of publication not identified] : ROYAL SOCIETY OF CHEMISTR, 2022 _z1788018982 _w(OCoLC)1331704492 |
856 | 4 | 0 |
_3EBSCOhost _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3580101 |
938 |
_aEBSCOhost _bEBSC _n3580101 |
||
994 |
_a92 _bN$T |
||
999 |
_c8840 _d8840 |